| Literature DB >> 24945323 |
Sandra P van Tongeren1, Hendrik I J Roest2, John E Degener1, Hermie J M Harmsen1.
Abstract
For some microbial species, such as Bacillus anthracis, the etiologic agent of the disease anthrax, correct detection and identification by molecular methods can be problematic. The detection of virulent B. anthracis is challenging due to multiple virulence markers that need to be present in order for B. anthracis to be virulent and its close relationship to Bacillus cereus and other members of the B. cereus group. This is especially the case in environments where build-up of Bacillus spores can occur and several representatives of the B. cereus group may be present, which increases the chance for false-positives. In this study we show the presence of B. anthracis-like bacteria and other members of the B. cereus group in a microbial community within the human environment of the International Space Station and their preliminary identification by using conventional culturing as well as molecular techniques including 16S rDNA sequencing, PCR and real-time PCR. Our study shows that when monitoring the microbial hygiene in a given human environment, health risk assessment is troublesome in the case of virulent B. anthracis, especially if this should be done with rapid, easy to apply and on-site molecular methods.Entities:
Mesh:
Year: 2014 PMID: 24945323 PMCID: PMC4063717 DOI: 10.1371/journal.pone.0098871
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
PCR oligonucleotide primers used in this study.
| Target gene | Primer | Sequence (5′–3′) | References |
|
| BC1 |
| Yamada et al. |
| BC2r |
| Yamada et al. | |
|
| BA1 |
| Yamada et al. |
| BA2r |
| Yamada et al. | |
|
| BT1 |
| Yamada et al. |
| BT2r |
| Adapted from Yamada et al. | |
| 16S rRNA | forward |
| (R. Rozeboom and P. Terpstra, personalcommunication); Hiraishi et al. |
| 16S rRNA | reverse |
| (R. Rozeboom and P. Terpstra, personalcommunication); Hiraishi et al. |
| BA_5345 | BA chrom F |
| based on Antwerpen et al. |
| BA chrom R |
| based on Antwerpen et al. | |
| BA chrom probe |
| based on Antwerpen et al. | |
|
| Lef F |
| based on Hadjinicolaou et al, 2009 |
| Lef R |
| based on Hadjinicolaou et al, 2009 | |
| Lef probe |
| based on Hadjinicolaou et al, 2009 | |
|
| CapC F |
| based on Hadjinicolaou et al, 2009 |
| CapC R |
| based on Hadjinicolaou et al, 2009 | |
| CapC probe |
| based on Hadjinicolaou et al, 2009 |
Bold: T7 and UP extension, respectively.
Abbreviations: FAM, carboxyfluorescein; CY, cyanine; BHQ, Black Hole Quencher.
Overview of isolate characteristics using several methodologies.
| Character |
|
|
|
| S1-R1P1-FB | S1-R4D1-FB | S1-R6TC1 | S1-R3O1-FB | S2-R3O1-FB-BA1 | S2-R4W1-FB-BA1 | S1-R1J2-FB | S1-R2T1-FB | S1-R4H1-FB | S2-R3J1-FB-BA1 | S1-R5C1-FB |
| 16S rDNA analysisby online database searches |
| ||||||||||||||
|
|
| Inconclusive | |||||||||||||
| PCR of | |||||||||||||||
|
| + | + | + | + | + | + | − | − | − | − | − | − | |||
|
| + | − | − | − | − | − | (+) | + | + | + | + | + | |||
|
| + | − | − | − | − | − | − | − | − | − | − | − | |||
| Colony morphology | ¤ | ¤ | ¤ | ¤ | ¤ | Δ | X | X | X | X | ¤ | ||||
| β-haemolysis | + | −/(+) | + | −/(+) | + | + | + | (+) | (+) | + | + | + | + | + | + |
| Motility | + | − | + | − | + | (+) | + | (+) | (+) | + | + | + | + | + | + |
| Parasporal crystals | − | − | + | − | − | − | − | − | − | − | − | − | − | − | − |
| Acetoin production | + | + | + | + | + | − | + | + | − | + | + | + | + | + | + |
| Casein hydrolysis | + | + | + | + | − | + | − | − | − | + | + | + | + | + | + |
| Penicillin susceptibility | R | S/(R) | R | R | R | R | R | R | R | R | R | R | R | R | |
| Capsule production | − | +/− | − | − | − | − | − | − | − | − | − | − | − | − | − |
| Gamma phage susceptibility | − | + | − | − | − | − | − | − | − | − | − | − | − | − | (+) |
| Arginine dihydrolase | v | − | + | V | + | + | + | + | + | − | + | + | + | + | + |
| Acid from: | |||||||||||||||
| Glycerol | + | − | + | + | − | − | − | − | − | − | − | − | − | − | − |
| Salicin | + | − | (+) | (+) | + | + | + | + | + | + | (+) | − | (+) | − | (+) |
| PEA | − | + | + | + | + | + | (+) | + | + | + | + | + | |||
| VITEK 2 Systems BCL card | |||||||||||||||
| L-aspartate arylamidase | ND | ND | ND | ND | − | − | − | − | − | − | − | − | − | − | + |
| Leucine arylamidase | ND | ND | ND | ND | + | + | + | (+) | + | + | (+) | (+) | (+) | + | + |
| Alanine arylamidase | ND | ND | ND | ND | + | + | + | + | + | + | − | − | − | − | − |
| Tyrosine arylamidase | ND | ND | ND | ND | + | + | (+) | + | + | + | + | + | + | + | + |
| Cyclodextrine | ND | ND | ND | ND | − | − | − | − | + | − | − | − | − | (+) | − |
| Glycine arylamidase | ND | ND | ND | ND | − | − | − | − | − | − | + | − | (−) | − | (−) |
| D-mannose | ND | ND | ND | ND | − | − | − | − | − | + | − | − | − | − | − |
| N-acetyl-D-glucosamine | ND | ND | ND | ND | + | + | + | + | + | + | + | − | + | + | (−) |
| β-glucosidase | ND | ND | ND | ND | + | + | + | + | − | + | − | − | − | − | − |
| Pyruvate | ND | ND | ND | ND | (+) | + | + | (+) | + | (+) | (+) | + | + | + | + |
| α-glucosidase | ND | ND | ND | ND | − | − | − | (+) | + | − | − | − | (−) | (−) | − |
| Growth in 6.5% NaCl | ND | ND | ND | ND | + | + | + | + | + | − | + | + | + | + | + |
| Kanamycin susceptibility | ND | ND | ND | ND | R | R | R | R | S | S | R | R | R | R | R |
| Tetrazolium red | ND | ND | ND | ND | − | + | (−) | + | − | − | − | + | (−) | + | − |
Abbreviations: +, positive; v, variable; (+) or (−), weak reaction; −, negative; S, susceptible; R, resistant; ND, not determined. Symbols for colony morphology indicate similarity and differences. All data were obtained in this study, except data for B. cereus, B. anthracis, B. thuringiensis and B. mycoides that were compiled [21], [22].
*Gamma phage susceptibility is not truly specific for B. anthracis [32].
16S rDNA sequence signature comparison of isolates according to the Sacchi et[31] type scheme.
| 16S type | Strain | Nucleotide position | ||||||||||||
| 77 | 90 | 92 | 182 | 189 | 192 | 200 | 208 | 1015 | 1036 | 1045 | 1146 | 1462 | ||
| type 9 | A | T | T | C | A | C | T | G | A | T | A | A | T | |
| S1-R1P1-FB | A | T | T | C (t) | A | C | T | G | A (c) | T | A | A | T (a) | |
| S1-R6TC1 | A | T | T | C (t) | A | C | T | G | A (c) | T | A | A | T (a) | |
| S1-R3O1-FB | A | T | T | C (t) | A | C (t) | T | G | A (c) | T | A | A | T (a) | |
| S1-R4D1-FB | A | T | T | C (t) | A | C (t) | T | G | A (c) | T | A | A | T (a) | |
| S2-R3O1-FB-BA1 | A (g) | T | T | C | A | C (t) | T | G | A (c) | T | A | A | T (a) | |
| type 13 | A | T | T | C | A | C | T | G | C | T | A | T | T | |
| type 6 | A | T | T | C | A | C | T | G | C | T | A | W | T | |
| S1-R1J2-FB | A | T | T | C (t) | A | C | T | G | C | T | A | T | T | |
| S1-R2T1-FB | A | T | T | C (t) | A | C | T | G | C | T | A | T | T | |
| S1-R4H1-FB | A | T | T | C (t) | A | C | T | G | C | T | A | T | T | |
| S2-R3J1-FB-BA1 | A | T | T | C (t) | A | C | T | G | C | T | A | T | T | |
| S1-R5C1-FB | A | T | T | C (t) | A | C | T | G | C | T | A | T | T | |
|
| A | T | T | T | A | T | T | G | A | T | A | A | A | |
|
| A | T | T | T | A | T | T | G | A | T | A | A | A | |
| S2-R4W1-FB-BA1 | A | T | T | T | A | T | T | G | A | T | A | A | A | |
Abbreviations: R, A or G nucleotide; Y, C or T nucleotide; M, A or C nucleotide; W, A or T nucleotide. Nucleotides between brackets indicate a weak double signal of that nucleotide at that position.